Zyprexa Relprevv 405 MG Injection
- RxCUI
- 1718928
- RxNorm name
- Zyprexa Relprevv 405 MG Injection
- Display name
- Zyprexa Relprevv 405 MG Injection
- Full name
- Zyprexa Relprevv 405 MG Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYPREXA Relprevv | OLANZAPINE PAMOATE | H2-Pharma LLC | 11544cba-64a9-49cb-8d74-da228053b252 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 1718928 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 11544cba-64a9-49cb-8d74-da228053b252 | ZyPREXA Relprevv 405 MG Injection [PSN] · olanzapine 405 MG Injection [Zyprexa] [SBD] · Zyprexa 405 MG Injection [SY] · Zyprexa Relprevv 405 MG Injection [SY] | 4 | 68 | These highlights do not include all the information needed to use ZYPREXA RELPREVV safely and effectively. See full prescribing information for ZYPREXA RELPREVV. ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension Initial U.S. Approval: 1996 | 20260519 |